 |
To print: Click here or Select File and then Print from your browser's menu
Biocryst receives US FDA approval for human test of influenza drug
Monday, December 26, 2005 09:00 IST
Birmingham
BioCryst Pharmaceuticals has received from the US Food and Drug Administration a verbal approval to begin studies with intravenous peramivir, the company's influenza neuraminidase inhibitor.
Read complete story ...
(You will need to login first to read this story.)
|
